Bio International 2024 Abzena at BIO 2024: Showcasing innovation in cell line development technology 15-May-2024 By Isabel Cameron Abzena, an end-to-end CDMO for biologics and bioconjugates, will be presenting its latest AbZelect and AbZelectPRO cell line development (CLD) platforms and more at BIO 2024.
Abzena creates offering for drug candidate optimization 29-Mar-2019 By Maggie Lynch Abzena launches a developability assessment and optimization service to assist customers in selecting and developing lead candidates for manufacture.